Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,401 | 7,365 | 8,624 | 4,952 | 6,777 |
| TOTAL | $5,136 | $8,172 | $9,469 | $5,935 | $7,674 |
| Non-Current Assets | |||||
| Intangibles | 6 | 6 | 6 | 6 | 6 |
| Other Non-Current Assets | 350 | 0 | 0 | 0 | 0 |
| TOTAL | $356 | $6 | $6 | $6 | $6 |
| Total Assets | $5,491 | $8,178 | $9,475 | $5,941 | $7,680 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 649 | 247 | 442 | 196 | 190 |
| Accrued Expenses | 857 | 846 | 240 | 193 | 349 |
| TOTAL | $1,505 | $1,093 | $682 | $390 | $539 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,505 | $1,093 | $682 | $390 | $539 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28 | 23 | 22 | 17 | 17 |
| Common Shares | 14 | 14 | 13 | 11 | 10 |
| Retained earnings | -31,520 | -28,051 | -24,715 | -22,904 | -20,627 |
| TOTAL | $3,986 | $7,085 | $8,793 | $5,551 | $7,141 |
| Total Liabilities And Equity | $5,492 | $8,178 | $9,475 | $5,941 | $7,680 |